Many encouraging leads are emerging to combat the coronavirus, but they have yet to pass clinical trials.(Shutterstock)

Memento Covid-19 : A quick review before the start of the school year

Since the discovery of SARS-CoV-2 in China on January 9, 2020, we have been inundated with more or less verified information on the pandemic. It is useful to take stock of the scientific knowledge on the subject, with Jean-Marc Sabatier*.

coronavirus structure (

Schematic structure of the SARS-CoV-2 coronavirus (

Covid-19: the dangers of the third dose of the vaccine!

The current composition of vaccines uses so-called “facilitating” antibodies that promote infection by the SARS-CoV-2 virus that causes Covid-19 disease. Explanations with Dr. Jean-Marc Sabatier, Research Director at CNRS and PhD in Cell Biology and Microbiology, affiliated with the Institute of NeuroPhysiopathology (INP), at the University of Aix-Marseille.